Division of Cardiovascular Surgery, The Labatt Family Heart Centre, The Hospital for Sick Children, and University of Toronto, Toronto, Ontario, Canada.
Ann Thorac Surg. 2012 Dec;94(6):2061-9. doi: 10.1016/j.athoracsur.2012.04.048. Epub 2012 Aug 9.
The durability of atrioventricular valve (AVV) repair and risk factors for recurrent AVV regurgitation (AVVR) and reintervention in single-ventricle patients are not well defined.
Among 66 single-ventricle patients who underwent AVV repair between 1998 and 2011, 58 hospital survivors (88%) were retrospectively reviewed. Freedom from recurrent AVVR and reintervention were analyzed with Kaplan-Meier analysis. Predictors for recurrent AVVR, ventricular dysfunction, and reintervention were analyzed using regression analysis.
Significant (more than mild+) AVVR developed in 47 patients (81%) during mean follow-up of 37 months (range, 0.2 to 103 months). Freedom from significant AVVR was 23.8% at 1 year and 16.9% at 5 years. Reintervention was performed in 12 patients (26%) at a mean of 24 months (range, 2 to 64 months) after the initial repair. Freedom from reintervention was 92.3% at 1 year and 75.3% at 5 years. There were 11 late deaths (19%). Predictors for recurrent AVVR included repair at stage II (p=0.020) and cardiopulmonary bypass time (p=0.014). Predictors for reintervention included valvuloplasty as a repair technique (p=0.013), cardiopulmonary bypass time (p=0.002), aortic cross-clamp time (p=0.003), and significant residual intraoperative AVVR (p=0.012). Intraoperative ventricular dysfunction (p<0.001), aortic cross-clamp time (p=0.005), and cleft as the mechanism of regurgitation (p=0.023) predicted postrepair ventricular dysfunction.
Although significant AVVR developed in most patients within 1 year of repair, the need for repeat valve repair is relatively low if ventricular function is preserved. Ventricular function after repair did not predict late survival but was related to the longevity of AVV competence and subsequent risk for reintervention.
房室瓣(AVV)修复的耐久性以及单心室患者复发 AVV 反流(AVVR)和再次干预的风险因素尚不清楚。
在 1998 年至 2011 年间接受 AVV 修复的 66 例单心室患者中,回顾性分析了 58 例住院存活患者(88%)。采用 Kaplan-Meier 分析评估无复发性 AVVR 和再次干预的情况。采用回归分析评估复发 AVVR、心室功能障碍和再次干预的预测因素。
在平均 37 个月(0.2 至 103 个月)的随访中,47 例(81%)患者出现明显(大于轻度+)AVVR。1 年时无明显 AVVR 的比例为 23.8%,5 年时为 16.9%。在初始修复后平均 24 个月(2 至 64 个月),12 例患者(26%)再次接受干预。1 年时无再次干预的比例为 92.3%,5 年时为 75.3%。有 11 例患者死亡(19%)。复发 AVVR 的预测因素包括在 II 期进行修复(p=0.020)和体外循环时间(p=0.014)。再次干预的预测因素包括瓣膜成形术作为修复技术(p=0.013)、体外循环时间(p=0.002)、主动脉阻断时间(p=0.003)和术中明显的残余 AVVR(p=0.012)。术中心室功能障碍(p<0.001)、主动脉阻断时间(p=0.005)和反流机制为裂孔(p=0.023)预测了修复后的心室功能障碍。
尽管大多数患者在修复后 1 年内出现明显的 AVVR,但如果心室功能得到保留,再次进行瓣膜修复的需求相对较低。修复后的心室功能并未预测晚期存活率,但与 AVV 功能的持久性和随后再次干预的风险有关。